Key statistics
On Monday, Day One Biopharmaceuticals Inc (DAWN:NSQ) closed at 6.50, 6.91% above its 52-week low of 6.08, set on May 16, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.48 |
---|---|
High | 6.56 |
Low | 6.36 |
Bid | 6.17 |
Offer | 6.70 |
Previous close | 6.47 |
Average volume | 1.62m |
---|---|
Shares outstanding | 101.36m |
Free float | 83.69m |
P/E (TTM) | -- |
Market cap | 655.82m USD |
EPS (TTM) | -0.6604 USD |
Data delayed at least 15 minutes, as of Jun 30 2025 21:00 BST.
More ▼
- Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
- Day One Reports First Quarter 2025 Financial Results and Corporate Progress
- Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025
- Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress
- Day One to Report Fourth Quarter and Full-Year 2024 Financial Results Tuesday, February 25, 2025
- Day One Reports Preliminary 2024 OJEMDA™ Net Product Revenue and Highlights 2025 Corporate Priorities
- Day One to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
- Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference
- Day One Reports Third Quarter 2024 Financial Results and Corporate Progress
More ▼